Actively Recruiting
The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation
Led by Kirsehir Ahi Evran Universitesi · Updated on 2024-11-27
150
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
According to the 2024 GOLD guidelines, Chronic Obstructive Pulmonary Disease (COPD) is defined as heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. COPD is one of the leading causes of mortality and morbidity in Turkey and worldwide. Since COPD is an incurable and lifelong disease, it is important for patients to have high levels of self-management. The main questions it aims to answer are: 1. Does self-management education and telephone follow-up intervention effect self-care agency and symptom management in people with COPD exacerbation? 2. Does self-management education effect self-care agency and symptom management in people with COPD exacerbation? This study will evaluate the effect of self-management education and telephone follow-up on self-care agency and symptom management. Patients hospitalized with COPD exacerbation will be trained in the hospital and will be followed up by phone call after discharge. During the study, 3 groups were planned; Group 1 will be educated and followed up by telephone Group 2 will only receive education and no telephone follow-up. Group 3 will not receive education and telephone follow-up, only standard care. It is planned to collect the data from the patients at the beginning of the study, at 1, 3 and 6 months. Main outcomes: * Level of self-care agency * Level of symptom management The results obtained will be interpreted by comparing between 3 groups.
CONDITIONS
Official Title
The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with COPD for the last 1 year
- Documented diagnosis of GOLD stage III or IV COPD by pulmonary function testing
- Hospitalized for acute exacerbation of COPD
- Hospitalized for at least 3 days
- Have a personal mobile phone and can use it
- Conscious and oriented to answer questions
- Voluntary participation
You will not qualify if you...
- Under 18 years old
- Withdrawal from the study at any phase
- Unable to be contacted by phone or mobile phone
- Patient death
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kirsehir Training and Research Hospital
Kırşehir, Turkey (Türkiye), 40200
Actively Recruiting
Research Team
Y
Yasemin CEYHAN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here